文献速递腹部骨肌技术与安全CTMR

对比增强双源双能CT定量肝脏与肌肉脂肪:与多回波Dixon MRI比较

Quantification of liver and muscular fat using contrast-enhanced Dual Source Dual Energy Computed Tomography compared to an established multi-echo Dixon MRI sequence.
PubMed 文献 · Eur J Radiol · 2021-07-06

回顾性单中心研究纳入81例患者共90对检查,以多回波Dixon MRI为参考标准,评估门静脉期双源双能CT定量肝脏及肌肉脂肪的可行性。结果显示肝脏脂肪DECT较MRI系统性低估约1.7%,但相关性良好(Spearman 0.73);竖脊肌和腰大肌脂肪定量两种方法无显著差异。

要点

  • 门静脉期DECT可用于肝脏和肌肉脂肪定量,与MRI相关性良好至优秀。
  • DECT测肝脏脂肪较MRI系统性低估,平均差异-1.7%,报告时需注意。
  • 竖脊肌和腰大肌脂肪DECT与MRI无显著差异,肌肉脂肪定量更可靠。

核心结论

  • 门静脉期双源双能CT定量肝脏和肌肉脂肪是可行的,与多回波Dixon MRI相关性良好至优秀。
  • DECT对肝脏脂肪含量存在系统性低估,但竖脊肌和腰大肌脂肪定量与MRI无显著差异。

研究设计与样本

  • 回顾性单中心IRB批准研究,最终纳入81例患者共90对检查。
  • 纳入2017年行肝脏多回波Dixon MRI及腹部对比增强DECT的患者,并补充2018年肝脂肪>5%行MRI和DECT检查的患者。
  • 以多回波Dixon MRI估算的质子密度脂肪分数为参考标准,DECT为门静脉期对比增强双源双能扫描。
  • 由操作者在肝脏实质、竖脊肌和腰大肌放置一致的兴趣区手动分析参数图。

诊断标准与关键数值

  • MRI肝脏脂肪定量中位数为3.8%(IQR 2.2-8.2%),DECT为1.8%(IQR 0-6.3%),差异有统计学意义(p < 0.001)。
  • 肝脏脂肪DECT与MRI的Spearman相关系数为0.73。
  • Bland-Altman分析显示DECT系统性低估肝脏脂肪,平均差异为-1.7%。
  • 竖脊肌脂肪定量DECT与MRI差异无统计学意义(p = 0.257),腰大肌亦无显著差异(p = 0.208)。

临床应用与阅片要点

  • 门静脉期DECT可用于机会性肝脏和肌肉脂肪定量,但肝脏脂肪值较MRI偏低,解读时需考虑系统性低估。
  • 肌肉脂肪定量(竖脊肌、腰大肌)DECT与MRI一致性较好,可作为肌少症或肌肉脂肪浸润的辅助评估。
  • 兴趣区应放置在肝脏实质、竖脊肌和腰大肌,并与MRI测量位置保持一致以利于比较。

局限性

  • 回顾性单中心研究,样本量有限(81例患者90对检查)。
  • MRI与DECT检查中位间隔48天,期间脂肪含量可能变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To investigate the feasibility of liver fat quantification in contrast-enhanced dual source dual energy computed tomography (DECT) using multi-echo Dixon magnetic resonance imaging (MRI) as reference standard.

METHOD: Patients who underwent MRI of the liver including a multi-echo Dixon sequence for estimation of proton density fat fraction in 2017 as well as contrast-enhanced DECT imaging of the abdomen were included in this retrospective, monocentric IRB approved study. Furthermore, patients with a hepatic fat amount >5% who were examined in 2018 with MRI and DECT were included. The final study group consisted of 81 patients with 90 pairs of examinations. Analysis of parameter maps was performed manually using congruent regions of interest which were placed in the liver parenchyma, in the erector spinae muscles, and psoas major muscles.

RESULTS: Mean patient age was 61 ± 13 years. Median time between MRI and DECT was 48 days. MRI liver fat quantification resulted in a median of 3.8% (IQR: 2.2-8.2%) compared to 1.8% (IQR: 0-6.3%) in DECT (p < 0.001), with a Spearman correlation of 0.73. Bland-Altman analysis resulted in a systematic underestimation of liver fat in DECT, with a mean difference of -1.7%. Fat quantification in the erector spinae muscles (p = 0.257) and the psoas major muscles (p = 0.208) was not significantly different in DECT compared to MRI.

CONCLUSIONS: Liver and muscular fat quantification in portal-venous phase DECT is feasible with good to excellent correlation compared to a multi-echo Dixon MRI sequence analysis. While there is an underestimation of the liver fat content in DECT, there are no significant differences between DECT and MRI fat quantification of the erector spinae and psoas major muscles.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Gassenmaier S, Kähm K, Walter SS, et al. Quantification of liver and muscular fat using contrast-enhanced Dual Source Dual Energy Computed Tomography compared to an established multi-echo Dixon MRI sequence. Eur J Radiol. 2021. PMID: 34271430. doi:10.1016/j.ejrad.2021.109845

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。